Pharmaco-Kinesis Corporation

Pharmaco-Kinesis Corporation is an early-stage high technology medical device company that aims to optimize healing of the human body through proprietary local Smart Drug Delivery Systems™ (SDDS) and associated advanced devices to measure biological responses. Our lead product is the Metronomic Biofeedback Pump™ (MBP), a potentially revolutionary implantable infusion pump for local drug delivery that uses advanced microfluidic, diagnostic and control mechanisms to deliver a variable, remotely programmable, metronomic combination of tumor fighting medications. In our first planned application, the MBP is expected to be a significant leap forward in the treatment of leptomeningeal carcinomatosis and other deadly brain cancers. In addition, PKC has a number of product technologies for which patents have been filed or are under development, including a VEGF BioSensor™, which is a novel, solid-state biosensor for label-free detection of vascular endothelial growth factor (VEGF), and an Intelligent Interbody Fusion Device, an implanted device for controlled, local delivery of BMP-2, a medication that promotes bone growth following spinal surgery.

• Employees 11
• Founded 2016
• Annual Revenue $4496000
• Total Funding $141655154